Company Overview

Glow Lifetech Corp. is a Canada-based biotechnology company focused on developing and commercializing drug delivery technologies, with a primary emphasis on cannabinoid and nutraceutical applications. The company operates at the intersection of biotechnology, life sciences, and the cannabis-derived health and wellness industry, positioning itself as a technology provider rather than a consumer-facing brand. Its core value proposition centers on improving bioavailability, stability, and dosing precision of active compounds.

The company’s primary business activity is the development of its proprietary MyCell™ technology, a plant-based, water-soluble delivery system designed to enhance the absorption of cannabinoids and other active ingredients. Glow Lifetech Corp. was incorporated in Canada and became publicly listed on the Canadian Securities Exchange under the ticker GLOW. Its evolution reflects a strategic shift from early-stage life sciences exploration toward applied drug delivery solutions, particularly following the acquisition of MyCell Sciences Inc., which materially shaped its current technology focus.

Business Operations

Glow Lifetech Corp. operates primarily through its wholly owned subsidiary Glow LifeTech Ltd., which holds and develops the company’s intellectual property. The company’s operations are organized around a single reportable business segment: biotechnology and drug delivery technology development, with revenue generation expected through licensing, formulation services, and potential commercialization partnerships. As of the most recent public disclosures, the company remains in a development-stage or early commercialization phase, and reported revenues have been limited or minimal.

Operational activities are primarily research, product formulation, intellectual property management, and regulatory-aligned development work. The company controls proprietary processes related to MyCell™, including encapsulation and solubilization techniques. There is no publicly verified evidence of large-scale manufacturing assets or long-term commercial supply contracts; where applicable, development and testing activities rely on third-party laboratories and partners. Data on recurring commercial partnerships remains limited and, in some cases, inconclusive based on available public sources.

Strategic Position & Investments

The strategic direction of Glow Lifetech Corp. centers on leveraging MyCell™ technology as a platform applicable across cannabinoids, functional foods, and nutraceuticals. Growth initiatives have emphasized expanding the technology’s applicability beyond THC and CBD into other bioactive compounds, as well as pursuing licensing or co-development arrangements with established consumer packaged goods or pharmaceutical-adjacent companies.

A key strategic investment was the acquisition of MyCell Sciences Inc., which provided the foundational intellectual property underpinning the company’s current operations. Beyond this transaction, publicly disclosed acquisitions or equity investments are limited. The company has signaled interest in emerging sectors such as plant-based therapeutics and precision dosing technologies, though commercialization timelines and financial impact remain uncertain based on publicly available disclosures.

Geographic Footprint

Glow Lifetech Corp. is headquartered in Canada, with its corporate and operational presence primarily concentrated in North America. Research, development, and administrative functions are conducted domestically, and the company’s regulatory and commercialization strategies have largely focused on the Canadian and broader North American markets.

While the company has referenced potential global applicability of its technology, there is limited verified public information confirming active operations, subsidiaries, or revenue-generating activities outside North America. Any international market exposure appears to be strategic or exploratory rather than operational at this stage, and detailed geographic revenue breakdowns are not consistently disclosed.

Leadership & Governance

The leadership team of Glow Lifetech Corp. comprises executives with experience in biotechnology, cannabis, and early-stage public company management. The company was founded and is led by individuals closely associated with the development and promotion of MyCell™ technology, reflecting a technology-driven leadership philosophy focused on intellectual property and applied science.

Key executives include:

• Rob Carducci – Chief Executive Officer
• Brad Marshall – Chief Technology Officer
• Mark Achleitner – Chief Financial Officer
• Leonard D. Harris – Director

The leadership’s stated strategic vision emphasizes disciplined technology development, regulatory alignment, and long-term value creation through partnerships rather than rapid consumer brand expansion. Certain governance and executive role details may vary over time, and some disclosures are limited; where discrepancies exist across public filings and market disclosures, data is inconclusive based on available public sources.